Human Ubc16/UBE2W protein (Recombinant) (His-Tag) (STJP017214)

SPECIFICATIONS
HostE.coli
ImmunogenHuman
STJP017214
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRecombinant-Human Ubc16/UBE2W-His-Tag protein was developed from e.coli and has a target region of His-Tag. For use in research applications.
ApplicationsSDS-PAGE
HostE.coli
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

Concentration1 mg/mL
FormulationLiquid In Phosphate-Buffered Saline (pH 7.4) containing 10% Glycerol
Storage InstructionFor short term storage, keep at +2C to +8C for up to 1 week. For long term storage, aliquot and store at-20C, and avoid repeat freeze-thaw cycles.

Target Information

Gene SymbolUBE2W
Gene ID55284
Uniprot IDUBE2W_HUMAN
Accession NumberNP_060769.5
ImmunogenHuman
Immunogen Region1-151aa
Immunogen Sequence MASMQKRLQK ELLALQNDPP PGMTLNEKSV QNSITQWIVD MEGAPGTLYE GEKFQLLFKF SSRYPFDSPQ VMFTGENIPV HPHVYSNGHI CLSILTEDWS PALSVQSVCL SIISMLSSCK EKRRPPDNSF YVRTCNKNPK KTKWWYHDDT C

Additional Info

Tissue Specificity Widely expressed, with highest expression in brain, liver, pancreas and heart.
Post Translational Modifications Autoubiquitinated at Met-1.
Function Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. Specifically monoubiquitinates the N-terminus of various substrates, including ATXN3, MAPT/TAU, POLR2H/RPB8 and STUB1/CHIP, by recognizing backbone atoms of disordered N-termini. Involved in degradation of misfolded chaperone substrates by mediating monoubiquitination of STUB1/CHIP, leading to recruitment of ATXN3 to monoubiquitinated STUB1/CHIP, and restriction of the length of ubiquitin chain attached to STUB1/CHIP substrates by ATXN3. After UV irradiation, but not after mitomycin-C (MMC) treatment, acts as a specific E2 ubiquitin-conjugating enzyme for the Fanconi anemia complex by associating with E3 ubiquitin-protein ligase FANCL and catalyzing monoubiquitination of FANCD2, a key step in the DNA damage pathway. In vitro catalyzes 'Lys-11'-linked polyubiquitination. UBE2W-catalyzed ubiquitination also occurs in the presence of inactive RING/U-box type E3s, i.e. lacking the active site cysteine residues to form thioester bonds with ubiquitin, or even in the absence of E3, albeit at a slower rate.
Protein Name Ubiquitin-Conjugating Enzyme E2 W
E2 Ubiquitin-Conjugating Enzyme W
N-Terminal E2 Ubiquitin-Conjugating Enzyme
N-Terminus-Conjugating E2
Ubiquitin Carrier Protein W
Ubiquitin-Conjugating Enzyme 16
Ubc-16
Ubiquitin-Protein Ligase W
Database Links Reactome: R-HSA-8866652
Reactome: R-HSA-983168
Cellular Localisation Nucleus
In The Nucleus
Colocalizes With Fancl
Alternative Protein Names Ubiquitin-Conjugating Enzyme E2 W protein
E2 Ubiquitin-Conjugating Enzyme W protein
N-Terminal E2 Ubiquitin-Conjugating Enzyme protein
N-Terminus-Conjugating E2 protein
Ubiquitin Carrier Protein W protein
Ubiquitin-Conjugating Enzyme 16 protein
Ubc-16 protein
Ubiquitin-Protein Ligase W protein
UBE2W protein
UBC16 protein

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins